Toxic epidermal necrolysis medical therapy: Difference between revisions
Created page with "__NOTOC__ {{Toxic epidermal necrolysis}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. {{CMG}}..." |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Toxic epidermal necrolysis}} | {{Toxic epidermal necrolysis}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
{{CMG}} | {{CMG}} | ||
Revision as of 00:35, 11 February 2013
|
Toxic epidermal necrolysis Microchapters |
|
Differentiating Toxic Epidermal Necrolysis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Toxic epidermal necrolysis medical therapy On the Web |
|
American Roentgen Ray Society Images of Toxic epidermal necrolysis medical therapy |
|
Risk calculators and risk factors for Toxic epidermal necrolysis medical therapy |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
First Line: early withdrawal of culprit drugs, early referral and management in burn units or intensive care units, supportive management, nutritional support
Second Line: Intravenous immunoglobulin (IVIG) - Uncontrolled trials showed promising effect of IVIG on treatment of TEN; a randomized control trial is needed in the future to determine the efficacy of IVIG in TEN.
Third Line: cyclosporin, cyclophosphamide, plasmapheresis, pentoxifylline, N-acetylcysteine, ulinastatin, infliximab, Granulocyte colony-stimulating factors (if TEN associated-leukopenia)
Systemic steroids are unlikely to offer any benefits.